These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 4986220)
1. The epidemiology of severe haemolytic disease of the newborn. Kinnock S; Liley AW N Z Med J; 1970 Feb; 71(453):76-83. PubMed ID: 4986220 [No Abstract] [Full Text] [Related]
2. [Rh sensitization]. Drazancić A; Gorecan V; Barsić E Rad Med Fak Zagrebu; 1970; 18(2):89-105. PubMed ID: 4999735 [No Abstract] [Full Text] [Related]
3. [Anti-D prevention. Review and outlook for 1976]. Schneider J Fortschr Med; 1976 Nov; 94(31):1747-52. PubMed ID: 826466 [No Abstract] [Full Text] [Related]
4. [Practical experiences with the anti-D-IgG prevention of Rh-immunization]. Bergmann H; Leinzinger E; Pazdernik I; Haider M Wien Med Wochenschr; 1969 Jan; 119(1):9-12. PubMed ID: 4975236 [No Abstract] [Full Text] [Related]
7. The prevention of rhesus-isoimmunization. Davey M Clin Obstet Gynaecol; 1979 Dec; 6(3):509-30. PubMed ID: 92385 [No Abstract] [Full Text] [Related]
8. [The importance of central care of Rh-sensitized women for the prophylaxis of hemolytic disease of the newborn]. Holtorff J; Brey J; Nitzsche M Zentralbl Gynakol; 1969 May; 91(20):629-47. PubMed ID: 4984542 [No Abstract] [Full Text] [Related]
9. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979. Adams MM; Gustafson J Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934 [No Abstract] [Full Text] [Related]
10. Incidence of Rh iso-immunisation in pregnant women and erythroblastosis foetalis. Dutta RN J Indian Med Assoc; 1971 May; 56(9):267-9. PubMed ID: 5001303 [No Abstract] [Full Text] [Related]
11. Rh haemolytic disease of the newborn: the role of the laboratory. Tovey LA Med Lab Sci; 1982 Jul; 39(3):297-303. PubMed ID: 6813628 [No Abstract] [Full Text] [Related]
12. [On the prevention of Rh immunization in Sweden]. Bartsch FK; Bergman PO; Bååthe P; Dahlen-Nilsson I; Hansson LA; Ryttinger LA Bibl Haematol; 1969; 32():135-40. PubMed ID: 4980799 [No Abstract] [Full Text] [Related]
13. Transfusion support in the management of immune haemolytic disorders. Plapp FV; Beck ML Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130 [No Abstract] [Full Text] [Related]
14. A scheme for the detection of patients requiring treatment with anti-D gamma-globulin. Hall G; Hazelton JJ J Med Lab Technol; 1969 Jan; 26(1):44-8. PubMed ID: 4186154 [No Abstract] [Full Text] [Related]
15. [Prophylaxis against Rh-immunization]. Josephson B Lakartidningen; 1970 Dec; 67(51):6037-40. PubMed ID: 4992842 [No Abstract] [Full Text] [Related]
16. [Fetal erythroblastosis in Italy: yesterday and to-day]. Sansone G Pathologica; 1972; 64(927):17-26. PubMed ID: 4629914 [No Abstract] [Full Text] [Related]
17. The course of hemolytic disease of the newborn in Rh incompatibility. Lozińska D Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1117-20. PubMed ID: 107913 [TBL] [Abstract][Full Text] [Related]
18. [Influence of some social factors on perinatal mortality due to hemolytic disease of the newborn caused by Rh incompatibility]. Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A Arch Ostet Ginecol; 1969 Dec; 74(6):449-60. PubMed ID: 5000273 [No Abstract] [Full Text] [Related]
19. A Canadian Christmas. Sherrington AM Can Med Assoc J; 1980 Dec; 123(11):1089. PubMed ID: 6780178 [No Abstract] [Full Text] [Related]
20. Rh(D) haemolytic disease of the newborn: the changing scene. Urbaniak SJ Br Med J (Clin Res Ed); 1985 Jul; 291(6487):4-6. PubMed ID: 2990630 [No Abstract] [Full Text] [Related] [Next] [New Search]